Human CD27 HEK293T Stable Cell Line

Introduction

The Human CD27 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the CD27 protein. This cell line is derived from human embryonic kidney cells (HEK293T) that have been stably transfected with the gene for CD27, a member of the tumor necrosis factor receptor (TNFR) superfamily. CD27 is a cell surface protein that plays a critical role in immune responses and has been identified as a potential therapeutic target for various diseases. In this article, we will explore the structure, activity, and potential applications of the Human CD27 HEK293T Stable Cell Line, with a focus on its use in flow cytometry and as a therapeutic target.

Structure of CD27

The CD27 protein is a type I transmembrane protein that consists of 260 amino acids. It is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain contains several cysteine-rich repeats, which are important for ligand binding. The transmembrane domain anchors the protein to the cell membrane, while the cytoplasmic domain contains signaling motifs that are essential for the activation of downstream signaling pathways.

Activity of CD27

CD27 plays a crucial role in regulating immune responses. It is primarily expressed on the surface of T cells, B cells, and natural killer (NK) cells. Upon binding to its ligand, CD70, which is expressed on activated antigen-presenting cells, CD27 triggers a signaling cascade that leads to the activation and proliferation of T cells and the production of cytokines. This activation of T cells is critical for mounting an effective immune response against pathogens and cancer cells.
In addition to its role in immune responses, CD27 has also been implicated in the development and function of memory T cells. It is thought to play a role in the maintenance of long-term immune memory, which is essential for providing protection against recurrent infections.

Use in Flow Cytometry

The Human CD27 HEK293T Stable Cell Line is a valuable tool for studying the expression and function of CD27. This cell line stably expresses CD27 on its surface, allowing for the detection and analysis of CD27 using flow cytometry. Flow cytometry is a powerful technique that uses fluorescently labeled antibodies to identify and quantify specific cell surface markers. By using the Human CD27 HEK293T Stable Cell Line, researchers can easily analyze the expression of CD27 on different cell types and investigate its role in immune responses and memory formation.

Therapeutic Target

CD27 has emerged as a potential therapeutic target for various diseases, including cancer and autoimmune disorders. Several studies have shown that targeting CD27 can enhance anti-tumor immune responses and improve the efficacy of cancer immunotherapy. In addition, CD27 agonists have shown promising results in preclinical studies as potential treatments for autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus.
The Human CD27 HEK293T Stable Cell Line can be used to screen and evaluate potential CD27-targeted therapies. By studying the effects of different compounds on CD27 signaling and immune responses using this cell line, researchers can identify potential therapeutic candidates for further development.

Conclusion

The Human CD27 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of CD27. Its use in flow cytometry allows for the easy detection and analysis of CD27, while its potential as a therapeutic target makes it a valuable tool for drug discovery and development. With its ability to mimic the native expression of CD27, this cell line provides a reliable and relevant model for studying the role of CD27 in immune responses and its potential as a therapeutic target.